UroMems Completes €23 Million Series B Financing  

UroMems Completes €23 Million Series B Financing

 

Further participation from existing investors raised additional €7 million Additional capital to fund initiation of the first clinical trial of eAUS in patients suffering from stress urinary incontinence (SUI) caused by sphincter insufficiency. UroMems, developer and...